Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2014 Dec;33(12):2199-205.
doi: 10.1007/s10096-014-2188-6. Epub 2014 Jun 28.

Rapid emergence of daptomycin resistance in clinical isolates of Corynebacterium striatum… a cautionary tale

Affiliations
Case Reports

Rapid emergence of daptomycin resistance in clinical isolates of Corynebacterium striatum… a cautionary tale

E McElvania TeKippe et al. Eur J Clin Microbiol Infect Dis. 2014 Dec.

Abstract

The objective of this study was to investigate the observation of daptomycin resistance in Corynebacterium striatum, both in vivo and in vitro. We describe a case of C. striatum bacteremia in a patient with a left ventricular assist device (LVAD); the initial isolate recovered was daptomycin susceptible with a minimum inhibitory concentration (MIC) of 0.125 μg/ml. Two months later, and after daptomycin therapy, the individual became bacteremic with an isolate of C. striatum with a daptomycin MIC of >256 μg/ml. To study the prevalence of daptomycin resistance in C. striatum, clinical isolates of C. striatum were grown in broth culture containing daptomycin to investigate the emergence of resistance to this antimicrobial. Molecular typing was used to evaluate serial isolates from the index patient and the clinical isolates of C. striatum we assayed. In vitro analysis of isolates from the index patient and 7 of 11 additional C. striatum isolates exhibited the emergence of high-level daptomycin resistance, despite initially demonstrating low MICs to this antimicrobial agent. This phenotype was persistent even after serial subculture in the absence of daptomycin. Together, these data demonstrate that caution should be taken when using daptomycin to treat high-inoculum infections and/or infections of indwelling medical devices with C. striatum. To our knowledge, this is the first report characterizing the emergence of daptomycin resistance in C. striatum.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors declare that they have no conflict of interest.

Figures

Figure 1
Figure 1. Profile of three C. striatum isolates from our index patient
A. Dendogram illustrating the results of repPCR strain typing analysis of the three C. striatum isolates recovered from the index patient. All isolates have a SI ≥95%, illustrating that the infections were caused by a single strain type. B. Daptomycin MIC results as evaluated by Etest for the index patient's initial C. striatum bloodstream infection (top, left), C. striatum isolated from the blood stream 66 days later (top, center), and C. striatum isolated from tissue 78 days after the initial blood stream infection (top, right). Each isolate was grown overnight in broth culture in the absence (top row) and presence (bottom row) of daptomycin.

Similar articles

Cited by

References

    1. Gould IM, Miro JM, Rybak MJ. Daptomycin: the role of high-dose and combination therapy for Gram-positive infections. International journal of antimicrobial agents. 2013;42(3):202–210. doi: 10.1016/j.ijantimicag.2013.05.005. - DOI - PubMed
    1. Humphries RM, Pollett S, Sakoulas G. A current perspective on daptomycin for the clinical microbiologist. Clinical microbiology reviews. 2013;26(4):759–780. doi: 10.1128/CMR.00030-13. - DOI - PMC - PubMed
    1. Rybak JM, Barber KE, Rybak MJ. Current and prospective treatments for multidrug-resistant gram-positive infections. Expert opinion on pharmacotherapy. 2013;14(14):1919–1932. doi: 10.1517/14656566.2013.820276. - DOI - PubMed
    1. Corona Perez-Cardona PS, Barro Ojeda V, Rodriguez Pardo D, Pigrau Serrallach C, Guerra Farfan E, Amat Mateu C, Flores Sanchez X. Clinical experience with daptomycin for the treatment of patients with knee and hip periprosthetic joint infections. The Journal of antimicrobial chemotherapy. 2012;67(7):1749–1754. doi: 10.1093/jac/dks119. - DOI - PubMed
    1. Durante-Mangoni E, Casillo R, Bernardo M, Caianiello C, Mattucci I, Pinto D, Agrusta F, Caprioli R, Albisinni R, Ragone E, Utili R. High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012;54(3):347–354. doi: 10.1093/cid/cir805. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources